Upgrade to SI Premium - Free Trial

Freedom Capital Markets Starts AtriCure (ATRC) at Buy

April 1, 2026 7:21 AM
Freedom Capital Markets analyst Keith Hinton initiates coverage on Articure (NASDAQ: ARTC) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage